Carol Levin
Senior Health Economist
—
University of Washington, Dept. of Global Health
Dr. Carol Levin is an expert in conducting economic evaluations of new and modified health technologies and clinical/programmatic interventions for public health programs in developing countries. Before joining DCP3, Dr. Levin spend 12 years as a senior health economist at PATH, an international non-profit in global health, providing leadership in the economic analyses of health technologies and clinical/programmatic interventions for HIV/AIDS, maternal and child health interventions, immunization programming, cervical cancer screening and prevention and reproductive health. While at PATH, she conducted over 25 economic evaluations including cost or cost-effectiveness analyses related to the introduction of new vaccines, immunization/injection technologies (auto-disable syringes, retractable syringes, thermostable vaccines), vaccine supply chain logistics, reproductive health interventions or technologies (emergency contraception, safe abortion, HPV vaccination, visual inspection with acetic acid, rapid HPV testing) and diagnostics tests (rapid syphilis testing, nutrition diagnostics). Dr. Levin is a recognized technical expert in designing and implementing primary cost analyses, working with national public health specialists and local economists across three continents and over 10 countries, including Kenya, Ghana, Zimbabwe, Senegal Mozambique, South Africa, China, India, Vietnam, Indonesia, Peru, Nicaragua, Bolivia and Uganda. Dr. Levin participates in a number of expert working groups, technical advisory groups and requested consultations, serving as a technical advisor or expert to the WHO, GAVI, World Bank, PAHO, CDC, CIDA and DFID on economic evaluation (to support both global and country level activities).
While at PATH, she also designed and implemented interventions to advance child and maternal health and nutrition, including leading project teams to develop and introduce new diagnostic tools for assessing micronutrient malnutrition, as well as collaborating with the International Potato Center, University of Toronto and Emory University on the Mama SAHSA (Sweet Potato Action for Security and Health) project, an intervention designed and implemented to integrate agriculture and health service delivery to maximize nutritional benefits of orange fleshed sweet potato among pregnant women, their infants and children.
Before joining PATH in 2000, Dr. Levin was a Research Fellow at the International Food Policy Research Institute (IFPRI). While at IFPRI, she was outposted to Ghana for three years, as a policy advisor to Ghana’s National Development Planning Commission to strengthen capacity in the area of food and nutrition policy. She then spent four years at IFPRI headquarters in Washington, DC, conducting research on urban food and nutrition security, cost-effectiveness of micronutrient interventions, and food-based strategies to address micronutrient malnutrition. From October 1998 to March 2000, she was responsible for economic analysis undertaken under MOST—the USAID micronutrient project—including review of cost-effectiveness analysis and application of cost-effectiveness information to health/nutrition program planning/intervention choices. Dr. Levin holds a M.Sc. in international agricultural development from the University of California, Davis, and a PhD in agricultural economics from Cornell University.